{"id":5599,"date":"2016-10-26T16:25:28","date_gmt":"2016-10-26T14:25:28","guid":{"rendered":"https:\/\/www.fqeuskadi.org\/eu\/?page_id=5599"},"modified":"2023-01-23T15:04:17","modified_gmt":"2023-01-23T14:04:17","slug":"antibioterapia","status":"publish","type":"page","link":"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/","title":{"rendered":"ANTIBIOTERAPIA"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; next_background_color=&#8221;#ffffff&#8221; admin_label=&#8221;Hero&#8221; _builder_version=&#8221;4.17.4&#8243; background_image=&#8221;https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2020\/02\/pastillas-tratamientos.jpg&#8221; custom_padding=&#8221;110px|0px|160px|0px|false|false&#8221; custom_padding_tablet=&#8221;50px||50px||true&#8221; custom_padding_phone=&#8221;|||&#8221; bottom_divider_style=&#8221;asymmetric&#8221; bottom_divider_height=&#8221;50px&#8221; bottom_divider_flip=&#8221;horizontal&#8221; bottom_divider_height_tablet=&#8221;90px&#8221; bottom_divider_height_phone=&#8221;80px&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;2_3,1_3&#8243; _builder_version=&#8221;4.16&#8243; custom_width_px=&#8221;1280px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.19.4&#8243; text_font=&#8221;Montserrat||||||||&#8221; text_text_color=&#8221;rgba(255,255,255,0.7)&#8221; text_font_size=&#8221;20px&#8221; text_line_height=&#8221;1.8em&#8221; header_font=&#8221;Montserrat|700|||||||&#8221; header_font_size=&#8221;40px&#8221; header_line_height=&#8221;1.4em&#8221; header_6_font=&#8221;Montserrat|600||on|on||||&#8221; header_6_text_color=&#8221;#ffffff&#8221; header_6_font_size=&#8221;18px&#8221; header_6_letter_spacing=&#8221;2px&#8221; header_6_line_height=&#8221;1.5em&#8221; background_color=&#8221;rgba(59,193,254,0.67)&#8221; background_layout=&#8221;dark&#8221; max_width=&#8221;780px&#8221; custom_padding=&#8221;|9px||9px|false|true&#8221; custom_padding_tablet=&#8221;|9px||9px|false|true&#8221; custom_padding_phone=&#8221;|9px||9px|false|true&#8221; custom_padding_last_edited=&#8221;on|phone&#8221; text_font_size_tablet=&#8221;&#8221; text_font_size_phone=&#8221;15px&#8221; text_font_size_last_edited=&#8221;on|phone&#8221; header_font_size_tablet=&#8221;&#8221; header_font_size_phone=&#8221;20px&#8221; header_font_size_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1>ANTIBIOTERAPIAK INFEKZIOEI AURRE EGITEN LAGUNTZEN DIGU.<\/h1>\n<p>[\/et_pb_text][et_pb_button button_text=&#8221;Shop Medicines&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.16&#8243; custom_button=&#8221;on&#8221; button_text_size=&#8221;14px&#8221; button_bg_color=&#8221;#ff5473&#8243; button_border_width=&#8221;12px&#8221; button_border_color=&#8221;rgba(0,0,0,0)&#8221; button_border_radius=&#8221;100px&#8221; button_font=&#8221;Montserrat|700|||||||&#8221; button_use_icon=&#8221;off&#8221; background_layout=&#8221;dark&#8221; box_shadow_style=&#8221;preset3&#8243; button_border_radius_hover=&#8221;100px&#8221; button_bg_color_hover=&#8221;#ff6b86&#8243; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221; button_text_size__hover_enabled=&#8221;off&#8221; button_one_text_size__hover_enabled=&#8221;off&#8221; button_two_text_size__hover_enabled=&#8221;off&#8221; button_text_color__hover_enabled=&#8221;off&#8221; button_one_text_color__hover_enabled=&#8221;off&#8221; button_two_text_color__hover_enabled=&#8221;off&#8221; button_border_width__hover_enabled=&#8221;off&#8221; button_one_border_width__hover_enabled=&#8221;off&#8221; button_two_border_width__hover_enabled=&#8221;off&#8221; button_border_color__hover_enabled=&#8221;off&#8221; button_one_border_color__hover_enabled=&#8221;off&#8221; button_two_border_color__hover_enabled=&#8221;off&#8221; button_border_radius__hover_enabled=&#8221;on&#8221; button_border_radius__hover=&#8221;100px&#8221; button_one_border_radius__hover_enabled=&#8221;off&#8221; button_two_border_radius__hover_enabled=&#8221;off&#8221; button_letter_spacing__hover_enabled=&#8221;off&#8221; button_one_letter_spacing__hover_enabled=&#8221;off&#8221; button_two_letter_spacing__hover_enabled=&#8221;off&#8221; button_bg_color__hover_enabled=&#8221;on&#8221; button_bg_color__hover=&#8221;#ff6b86&#8243; button_one_bg_color__hover_enabled=&#8221;off&#8221; button_two_bg_color__hover_enabled=&#8221;off&#8221;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.19.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.19.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.19.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Antibioterapia, Fibrosi Kistikoaren pronostikoa hobetzeko funtsezko faktore bat izan da.<\/h3>\n<h3>Bronkioetako infekzio kronikoari zein gaizkiagotze infekziosoei aurre egiteko erabiltzen da.<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row custom_padding_last_edited=&#8221;on|phone&#8221; _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; custom_padding_tablet=&#8221;&#8221; custom_padding_phone=&#8221;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; custom_padding_tablet=&#8221;|||&#8221; custom_padding_phone=&#8221;|||&#8221; custom_padding_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221; padding_last_edited=&#8221;on|phone&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_divider disabled_on=&#8221;on||&#8221; _builder_version=&#8221;4.19.4&#8243; height=&#8221;8px&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;&#8221; custom_margin_last_edited=&#8221;on|desktop&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;2_5,3_5&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;2_5&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_toggle title=&#8221;Edukien aurkibidea&#8221; open=&#8221;on&#8221; closed_toggle_text_color=&#8221;#280400&#8243; closed_toggle_background_color=&#8221;rgba(36,179,207,0.18)&#8221; icon_color=&#8221;#280400&#8243; open_icon_color=&#8221;#280400&#8243; admin_label=&#8221;indice contenidos&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(36,179,207,0.2)&#8221; border_color_all=&#8221;#280400&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<ul>\n<li class=\"vertical-menu\"><a href=\"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/#seccion2\">INFEKZIOAK\/ JARRAIBIDEAK<\/a><\/li>\n<li class=\"vertical-menu\"><a href=\"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/#seccion3\">ANTIBIOTIKOAK-MOTAK-ERAGINAK<\/a><\/li>\n<li class=\"vertical-menu\"><a href=\"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/#seccion4\">LANGARGAILUAK<\/a><\/li>\n<li class=\"vertical-menu\"><a href=\"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/#seccion5\">KALYEDECO-ORKAMBI<\/a><\/li>\n<\/ul>\n<p>[\/et_pb_toggle][\/et_pb_column][et_pb_column type=&#8221;3_5&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; module_id=&#8221;infecciones&#8221; _builder_version=&#8221;4.16&#8243; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row disabled_on=&#8221;off|off|&#8221; _builder_version=&#8221;4.16&#8243; z_index_tablet=&#8221;500&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.17.4&#8243; header_2_font=&#8221;|600|||||||&#8221; header_2_text_align=&#8221;center&#8221; header_2_font_size=&#8221;48px&#8221; custom_margin=&#8221;||25px&#8221; animation_direction=&#8221;left&#8221; hover_enabled=&#8221;0&#8243; header_font_size_tablet=&#8221;&#8221; header_font_size_phone=&#8221;30px&#8221; header_font_size_last_edited=&#8221;on|phone&#8221; header_2_font_size_tablet=&#8221;&#8221; header_2_font_size_phone=&#8221;36px&#8221; header_2_font_size_last_edited=&#8221;on|phone&#8221; z_index_tablet=&#8221;500&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h2><strong><span style=\"color: #;\">Infekzio kronikoak <\/span>&#8211; <\/strong><span style=\"color: #000000;\"><strong><span style=\"color: #;\">jarraibideak eta ondorioak<\/span><\/strong><\/span><\/h2>\n<p>[\/et_pb_text][et_pb_divider divider_weight=&#8221;7px&#8221; _builder_version=&#8221;4.17.4&#8243; max_width=&#8221;16%&#8221; module_alignment=&#8221;center&#8221; custom_margin=&#8221;|||211px||&#8221; animation_direction=&#8221;right&#8221; hover_enabled=&#8221;0&#8243; z_index_tablet=&#8221;500&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p>[\/et_pb_divider][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|desktop&#8221; module_id=&#8221;seccion2&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#ffffff&#8221; custom_padding_tablet=&#8221;50px|0|50px|0&#8243; custom_padding_phone=&#8221;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.19.4&#8243; module_alignment=&#8221;left&#8221; hover_enabled=&#8221;0&#8243; border_style=&#8221;solid&#8221; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h4><u>INFEKZIO KRONIKOAK<\/u><\/h4>\n<p>Mikroorganismo batek, sei hilabeteko epean, gutxienez hiru karkaxa hazkuntzatan agerten denean, bronkioetako infekzio kroniko edo kolonizatutzat ematen da.<\/p>\n<p>Pseudomonas aeruginosak bronkioetako infekzio kronikoa duen pertsonentan, epe luzerako aerosolterapia antibiotikoak pertsonaren egonkortzea lortzen du, gaizkiagotze-agerraldiak murrizten ditu eta birika-funtzioa hobetzen du.<\/p>\n<p>Beste patogeno batzuek eragindako infekzio bronkial kronikoetan,\u00a0 ez dago ebidentzia nahikorik tratamendua jasotzeko bide honen efikazia zihurtatzeko.<\/p>\n<h4><strong>ANTIBIOTIKO GUZTIETARAKO <\/strong><strong>JARRAIBIDE KOMUNAK FK BIRIKETAKO INFEKZIOETARAKO<\/strong><\/h4>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Sendagai eta tratamendu guztiak gure neumologoak edo espezialistak agindu behar ditu.<\/li>\n<li>Lehenik eta behin, karkaxa kultibo bat egin behar da. Infekzioa zein bakterio-motak eragiten duen eta honi aurre egiteko antibiotikorik egokiena zein den ikusteko. Izan ere, pertsona bakoitzak bakterio ezberdinengatik kolonizatutak egon daitezke edo, antibiotiko bakoitzari erresistentzia ezberdina izan.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Faktore horiek eta infekzioaren zorroztasuna kontuan hartuta, tratamendua, emateko modua eta iraupena zehaztuko dira.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<blockquote>\n<p><strong>Infekzio horietako gehienak tratatu daitezke, baina, larritasunaren arabera, tratamendu desberdinak beharko dira: arnastuak, ahozkoak, zain barnekoak\u00a0 edo nebulizatuak.<\/strong><\/p>\n<\/blockquote>\n<p>&nbsp;<\/p>\n<p><a style=\"border: 0px solid #2e518b; padding: 10px; background-color: #7dff02; color: #280400; text-decoration: none; text-transform: uppercase; font-family: 'Helvetica', sans-serif; border-radius: 50px;\" href=\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2016\/10\/URGENCIAS-M\u00c9DICAS.pdf\" target=\"_blank\" rel=\"noopener\">LARRIALDIETARAKO ESKULIBURUA<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|desktop&#8221; module_id=&#8221;seccion3&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#eaeaea&#8221; custom_padding_tablet=&#8221;50px|0|50px|0&#8243; custom_padding_phone=&#8221;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_tabs active_tab_background_color=&#8221;#7dff02&#8243; inactive_tab_background_color=&#8221;#3bc1fe&#8221; _builder_version=&#8221;4.17.4&#8243; tab_text_color=&#8221;#280400&#8243; body_font=&#8221;||||||||&#8221; tab_font=&#8221;||||||||&#8221; border_radii=&#8221;on|1px|1px|1px|1px&#8221; border_color_all=&#8221;#000000&#8243; border_style=&#8221;solid&#8221; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_tab title=&#8221;AHO BIDEZKO ANTIBIOTIKOAK &#8221; _builder_version=&#8221;4.16&#8243; body_font=&#8221;||||||||&#8221; body_text_color=&#8221;#000000&#8243; body_line_height=&#8221;2em&#8221; tab_font=&#8221;||||||||&#8221; tab_text_color=&#8221;#280400&#8243; tab_line_height=&#8221;2em&#8221; body_line_height_tablet=&#8221;2em&#8221; body_line_height_phone=&#8221;2em&#8221; tab_line_height_tablet=&#8221;2em&#8221; tab_line_height_phone=&#8221;2em&#8221; global_colors_info=&#8221;{}&#8221;]Arnas gaizkiagotze arin edo ertainak antibiotikoen bidez tratatzean, ahal den guztietan, aho bidezko tratamenduak eta espektro zabaleko antibiotikoak behar dira erabili, gehienetan bi asteko ziklotan, karkaxan gehien agertu diren mikroorganismoen gainean eraginez.[\/et_pb_tab][et_pb_tab title=&#8221;IV ZAIN BARNEKO ZIZTADA BIDEZKO ANTIBIOTIKOAK&#8221; _builder_version=&#8221;4.16&#8243; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;2em&#8221; tab_font=&#8221;||||||||&#8221; tab_text_color=&#8221;#280400&#8243; tab_line_height=&#8221;2em&#8221; body_line_height_tablet=&#8221;2em&#8221; body_line_height_phone=&#8221;2em&#8221; tab_line_height_tablet=&#8221;2em&#8221; tab_line_height_phone=&#8221;2em&#8221; global_colors_info=&#8221;{}&#8221;]Arnas gaizkiagotze larrien kasuan, zain barneko ziztada bidezko tratamendua egin behar da, patogenoaren sentiberatasunaren araberako botika edo botikak baliatuz. Zain barneko bidea erabiliko da ere aho bidezko antibiotikoei erresistentziarik bada edo eraginkor ez badira.[\/et_pb_tab][et_pb_tab title=&#8221;ARNASTURIKO EDO LANGARREZTATURIKO ANTIBIOTIKOAK &#8221; _builder_version=&#8221;4.16&#8243; body_font=&#8221;||||||||&#8221; body_text_color=&#8221;#000000&#8243; body_line_height=&#8221;2em&#8221; tab_font=&#8221;||||||||&#8221; tab_text_color=&#8221;#280400&#8243; tab_line_height=&#8221;2em&#8221; body_line_height_tablet=&#8221;2em&#8221; body_line_height_phone=&#8221;2em&#8221; tab_line_height_tablet=&#8221;2em&#8221; tab_line_height_phone=&#8221;2em&#8221; global_colors_info=&#8221;{}&#8221;]Arnasturiko antibiotikoak sakon sartzen dira biriketako airebideetan.<\/p>\n<p>Horietako batzuk Pseudomona aeruginosa duten FK erien arnaste sintomak hobetzeko erabiltzen dira.<br \/>\nErabilienak Cayston, tobramicina eta abar dira, 28 eguneko zikloetan.<\/p>\n<p>Batzuetan txandakatzen dira, bakterioaren arabera eta eriaren egoeraren arabera.<br \/>\n Tobramicina, esate baterako, langargailuz hartu ohi da.<br \/>\n[\/et_pb_tab][\/et_pb_tabs][et_pb_text _builder_version=&#8221;4.16&#8243; module_alignment=&#8221;left&#8221; border_style=&#8221;solid&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4><span style=\"text-decoration: underline;\">ANTIBIOTIKOEKIKO ERRESISTENTZIA.<\/span><\/h4>\n<p><strong>Bereziki garrantzitsua da antibiotikoak medikuak agindu bezalaxe hartzea, baita infekzioaren sintomak jadanik desagertu badira ere.<\/strong> <span style=\"text-decoration: underline;\">Hala egin ezean, gerta daiteke oraindik geratzen diren bakterioak antibiotikoei erresistente bilakatzea eta horrek tratatzeko gaitzago bilakatuko ditu. <\/span><\/p>\n<p><strong>Antibiotikoei erresistente diren infekzioak egiazko arazoa da FK erientzat eta, denborak aurrera egin ahala, tratatzeko aukerak murriz ditzakete.<\/strong>.<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.16&#8243; module_alignment=&#8221;left&#8221; border_style=&#8221;solid&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4><span style=\"text-decoration: underline;\">ERAGINKORTASUNA ETA GERTA DAITEZKEEN ALBO ONDORIOAK.<\/span><\/h4>\n<p><strong>Antibiotikoak tratamendua hasi eta 48-72 ordutan hasi ohi dira eragina izaten. <\/strong><\/p>\n<ul>\n<li>Zeinahi botikak, antibiotikoek ere, eragin dezake albo ondorioren bat.<\/li>\n<li>Albo ondorioren bat edota sentsazio arraroren bat somatuz gero, medikuari esan behar zaio.&gt;<\/li>\n<li>Mediku taldeak erabakiko du ea ondorioen larriak tratamendua gelditzea edo murriztea ekarri behar duen<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|desktop&#8221; admin_label=&#8221;section&#8221; module_id=&#8221;seccion4&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#ffffff&#8221; custom_padding_tablet=&#8221;50px|0|50px|0&#8243; custom_padding_phone=&#8221;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;2_3,1_3&#8243; _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; link_font=&#8221;||||||||&#8221; module_alignment=&#8221;left&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4><span style=\"text-decoration: underline;\">LANGARGAILUAK, EGITEKOAK ETA ERABILERA.<\/span><\/h4>\n<p><strong>LIKIDOAK AEROSOL BILAKATZEN DITUZTEN GAILUAK DIRA<\/strong><\/p>\n<ul>\n<li>Langargailuen egitekoa botikak langar xehe moduan ematea da, aurpegi maskaren bidez edo aho mutur batez arnasgarriago izan daitezen.<\/li>\n<li>Gailu horiek konpresore bat dute eta hari egokituriko langargailua.<\/li>\n<li>Balia daitezke hala antibiotikoekin nola mukolitiko bronkio-zabaltzaileekin eta birusen kontrakoekin<\/li>\n<\/ul>\n<blockquote>\n<p>ERABAILI AURRETIK, ERIAK ESKUAK ONGI GARBITU BEHAR DITU BAKTERIOZKO EDO BESTELAKO KUTSADURARIK GERTA EZ DADIN.<\/p>\n<p>ERABILI ONDOREN, OSO GARRANTZI HANDIKOA DA LANGARGAILUA ONGI GARBITZEA, EKOIZLEAK ETA TEKNIKARI ESPEZIALISTAK EMAN AHOLKUEI JARRAIKIZ<\/p>\n<p>GEHIEN ERABILTZEN DIRENAK.<\/p>\n<\/blockquote>\n<p><a href=\"https:\/\/www.rendoneuropelaboratories.com\/eflowrapid\/\"><span style=\"text-decoration: underline;\">Eflow-Rapid<\/span><\/a><\/p>\n<p><a href=\"http:\/\/www.philips.es\/healthcare\/product\/HC85167\/i-neb-battery-powered-drug-delivery-system\"><span style=\"text-decoration: underline;\">I-NEB<\/span><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;ARNASTURIKO TRATAMENDURAKO GIDA ETA HIGIENE NEURRIAK &#8221; url=&#8221;http:\/\/www.respiralia.org\/wp-content\/uploads\/2012\/08\/Manual-higiene-definitivo.pdf&#8221; image=&#8221;https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2016\/10\/guia-tratamiento-inhalado.jpg&#8221; alt=&#8221;ARNASTURIKO TRATAMENDURAKO GIDA ETA HIGIENE NEURRIAK &#8221; _builder_version=&#8221;4.17.4&#8243; header_font=&#8221;||||||||&#8221; header_font_size=&#8221;16px&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; animation=&#8221;off&#8221; hover_transition_speed_curve=&#8221;linear&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_3,1_3,1_3&#8243; admin_label=&#8221;row&#8221; _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_gallery gallery_ids=&#8221;204817,204818&#8243; fullwidth=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; border_style=&#8221;solid&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_gallery][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_video src=&#8221;https:\/\/www.youtube.com\/watch?v=VOS99qQoBlk&#8221; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_video][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|desktop&#8221; module_id=&#8221;seccion5&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#eaeaea&#8221; custom_padding_tablet=&#8221;50px|0|50px|0&#8243; custom_padding_phone=&#8221;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;KALYDECO Ivacaftor .&#8221; image=&#8221;https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2016\/10\/image.jpg&#8221; _builder_version=&#8221;4.16&#8243; header_font=&#8221;||||on||||&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; border_style=&#8221;solid&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Kalydeco botikak ivacaftor izeneko osagai aktiboa dauka<br \/> Pilula moldean (150 mg) edo pikortaturik (50 mg eta 75 mg), zorrotan, dator.<br \/> Kalydeco <strong>Kalydeco erabilgarri da fibrosi kistikoa tratatzeko bi urte edo hortik gorako erietan<br \/> fibrosi kistikoaren transmintzaren konduktantzia erregulatzen duen proteinaren (CFTR) genean gerta daitezkeen bederatzi mutazioetako bat dutenean.<br \/> <strong>Honako mutazio hauek dira<\/strong><br \/> <strong><span style=\"color: #24b3cf;\"> G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N y S549R<\/span><br \/> (hobiaren mutazio izenaz ere ezagunak).<br \/> <strong>Kalydeco erabiltzen da fibrosi kistikoa duten 18 urtetik gorako eriak tratatzeko, CTFR genean R117H mutazioa dutenean ere.<\/strong><\/strong><\/strong><\/p>\n<p><strong><span style=\"text-decoration: underline;\">INFORMAZIO OSOA.<\/span><\/strong><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;ORKAMBI Lumacaftor\/Ivacaftor&#8221; image=&#8221;https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2016\/10\/ORKAMBI1.jpg&#8221; _builder_version=&#8221;4.16&#8243; header_font=&#8221;||||on||||&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; border_style=&#8221;solid&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Orkambi botika fibrosi kistikoaren tratamenduan erabiltzen da<br \/> <strong>F508del izeneko mutazio genetikoa duten 12 urte eta hortik gorako adineko erien kasuan.<\/strong><br \/> Mutazio horrek mukien eta digestio urinen ekoizpena erregulatzeko fibrosi kistikoaren transmintzaren konduktantziaren erregulatzaile (CFTR) izeneko proteinaren geneari eragiten dio. <br \/> Orkambi botika mutazioa aitarengandik eta amarengandik heredatu duten eriekin erabiltzen da, hau da, mutazioa CFTR genearen bi kopietan ageri duten eriekin.<br \/> Oraingoz, Europan erabili badaiteke ere, ez da Espainian erabiltzea baimendu.<\/p>\n<ul>\n<li>2016ko urrian, orain dela zenbait egun, Estatu Batuetako Vertex Pharmaceuticals konpainiak hango FDA agentzia arautzailearen baimena jaso du Orkambi -lumacaftor\/ivacaftor fibrosi kistikoa duten eta F508del mutazioaren bi kopiak dituzten 6-11 urte arteko haurrekin erabiltzeko<\/li>\n<\/ul>\n<p><strong><span style=\"text-decoration: underline;\">\u00a0INFORMAZIO OSOA.<\/span><\/strong><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;Ariketa fisikoa&#8221; url=&#8221;https:\/\/www.fqeuskadi.org\/eu\/ariketa-fisikoa\/&#8221; use_icon=&#8221;on&#8221; font_icon=&#8221;&#x23;||divi||400&#8243; icon_color=&#8221;rgba(28,18,12,0.8)&#8221; icon_placement=&#8221;left&#8221; _builder_version=&#8221;4.17.4&#8243; header_font=&#8221;||||||||&#8221; header_text_color=&#8221;#3bc1fe&#8221; header_font_size=&#8221;22px&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; animation=&#8221;off&#8221; header_font_size_tablet=&#8221;&#8221; header_font_size_phone=&#8221;18px&#8221; header_font_size_last_edited=&#8221;on|phone&#8221; border_style=&#8221;solid&#8221; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;Tratamenduari atxikitzeak&#8221; url=&#8221;https:\/\/www.fqeuskadi.org\/eu\/ariketa-fisikoa\/&#8221; use_icon=&#8221;on&#8221; font_icon=&#8221;&#x24;||divi||400&#8243; icon_color=&#8221;rgba(28,18,12,0.8)&#8221; icon_placement=&#8221;left&#8221; _builder_version=&#8221;4.16&#8243; header_font=&#8221;||||||||&#8221; header_text_color=&#8221;#3bc1fe&#8221; header_font_size=&#8221;22px&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; animation=&#8221;off&#8221; header_font_size_tablet=&#8221;&#8221; header_font_size_phone=&#8221;18px&#8221; header_font_size_last_edited=&#8221;on|phone&#8221; border_style=&#8221;solid&#8221; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ANTIBIOTERAPIAK INFEKZIOEI AURRE EGITEN LAGUNTZEN DIGU.Antibioterapia, Fibrosi Kistikoaren pronostikoa hobetzeko funtsezko faktore bat izan da. Bronkioetako infekzio kronikoari zein gaizkiagotze infekziosoei aurre egiteko erabiltzen da.INFEKZIOAK\/ JARRAIBIDEAKANTIBIOTIKOAK-MOTAK-ERAGINAKLANGARGAILUAKKALYEDECO-ORKAMBI Infekzio kronikoak &#8211; jarraibideak eta ondorioak INFEKZIO KRONIKOAK Mikroorganismo batek, sei hilabeteko epean, gutxienez hiru karkaxa hazkuntzatan agerten denean, bronkioetako infekzio kroniko edo kolonizatutzat ematen da. Pseudomonas aeruginosak bronkioetako [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-5599","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ANTIBIOTERAPIA - FQ EUSKADI<\/title>\n<meta name=\"description\" content=\"Antibioterapia Fibrosi Kistikoaren pronostiko hoberako eragile nagusietako bat izan da.Bronkioetako infekzio kronikoaren aurka erabiltzen da.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANTIBIOTERAPIA - FQ EUSKADI\" \/>\n<meta property=\"og:description\" content=\"Antibioterapia Fibrosi Kistikoaren pronostiko hoberako eragile nagusietako bat izan da.Bronkioetako infekzio kronikoaren aurka erabiltzen da.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/\" \/>\n<meta property=\"og:site_name\" content=\"FQ EUSKADI - ASOCIACI\u00d3N FIBROSIS QU\u00cdSTICA EUSKADI\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/fqeuskadi\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-23T14:04:17+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@fqeuskadi\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutua\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/\",\"url\":\"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/\",\"name\":\"ANTIBIOTERAPIA - FQ EUSKADI\",\"isPartOf\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/#website\"},\"datePublished\":\"2016-10-26T14:25:28+00:00\",\"dateModified\":\"2023-01-23T14:04:17+00:00\",\"description\":\"Antibioterapia Fibrosi Kistikoaren pronostiko hoberako eragile nagusietako bat izan da.Bronkioetako infekzio kronikoaren aurka erabiltzen da.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/#breadcrumb\"},\"inLanguage\":\"eu\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.fqeuskadi.org\/eu\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANTIBIOTERAPIA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#website\",\"url\":\"https:\/\/www.fqeuskadi.org\/\",\"name\":\"FQ EUSKADI - ASOCIACI\u00d3N FIBROSIS QU\u00cdSTICA EUSKADI\",\"description\":\"FQ Euskadi trabaja por las personas con Fibrosis qu\u00edstica. Desde Fq Euskadi ayudamos con nuestra labor y servicios a unas 90 familias con FQ.\",\"publisher\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fqeuskadi.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"eu\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#organization\",\"name\":\"ASOCIACI\u00d3N DE FIBROSIS QU\u00cdSTICA DE EUSKADI\",\"url\":\"https:\/\/www.fqeuskadi.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"eu\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/11\/2021_ARNASA_EUSKADI-1-e1637833605457.jpg\",\"contentUrl\":\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/11\/2021_ARNASA_EUSKADI-1-e1637833605457.jpg\",\"width\":1950,\"height\":532,\"caption\":\"ASOCIACI\u00d3N DE FIBROSIS QU\u00cdSTICA DE EUSKADI\"},\"image\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/fqeuskadi\/\",\"https:\/\/x.com\/fqeuskadi\",\"https:\/\/www.instagram.com\/fqeuskadi\/\",\"https:\/\/www.youtube.com\/channel\/UCyqLMZSfydAklJH1x-Js97w\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANTIBIOTERAPIA - FQ EUSKADI","description":"Antibioterapia Fibrosi Kistikoaren pronostiko hoberako eragile nagusietako bat izan da.Bronkioetako infekzio kronikoaren aurka erabiltzen da.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/","og_locale":"en_US","og_type":"article","og_title":"ANTIBIOTERAPIA - FQ EUSKADI","og_description":"Antibioterapia Fibrosi Kistikoaren pronostiko hoberako eragile nagusietako bat izan da.Bronkioetako infekzio kronikoaren aurka erabiltzen da.","og_url":"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/","og_site_name":"FQ EUSKADI - ASOCIACI\u00d3N FIBROSIS QU\u00cdSTICA EUSKADI","article_publisher":"https:\/\/www.facebook.com\/fqeuskadi\/","article_modified_time":"2023-01-23T14:04:17+00:00","twitter_card":"summary_large_image","twitter_site":"@fqeuskadi","twitter_misc":{"Est. reading time":"6 minutua"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/","url":"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/","name":"ANTIBIOTERAPIA - FQ EUSKADI","isPartOf":{"@id":"https:\/\/www.fqeuskadi.org\/#website"},"datePublished":"2016-10-26T14:25:28+00:00","dateModified":"2023-01-23T14:04:17+00:00","description":"Antibioterapia Fibrosi Kistikoaren pronostiko hoberako eragile nagusietako bat izan da.Bronkioetako infekzio kronikoaren aurka erabiltzen da.","breadcrumb":{"@id":"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/#breadcrumb"},"inLanguage":"eu","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.fqeuskadi.org\/eu\/antibioterapia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.fqeuskadi.org\/eu\/home\/"},{"@type":"ListItem","position":2,"name":"ANTIBIOTERAPIA"}]},{"@type":"WebSite","@id":"https:\/\/www.fqeuskadi.org\/#website","url":"https:\/\/www.fqeuskadi.org\/","name":"FQ EUSKADI - ASOCIACI\u00d3N FIBROSIS QU\u00cdSTICA EUSKADI","description":"FQ Euskadi trabaja por las personas con Fibrosis qu\u00edstica. Desde Fq Euskadi ayudamos con nuestra labor y servicios a unas 90 familias con FQ.","publisher":{"@id":"https:\/\/www.fqeuskadi.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fqeuskadi.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"eu"},{"@type":"Organization","@id":"https:\/\/www.fqeuskadi.org\/#organization","name":"ASOCIACI\u00d3N DE FIBROSIS QU\u00cdSTICA DE EUSKADI","url":"https:\/\/www.fqeuskadi.org\/","logo":{"@type":"ImageObject","inLanguage":"eu","@id":"https:\/\/www.fqeuskadi.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/11\/2021_ARNASA_EUSKADI-1-e1637833605457.jpg","contentUrl":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/11\/2021_ARNASA_EUSKADI-1-e1637833605457.jpg","width":1950,"height":532,"caption":"ASOCIACI\u00d3N DE FIBROSIS QU\u00cdSTICA DE EUSKADI"},"image":{"@id":"https:\/\/www.fqeuskadi.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/fqeuskadi\/","https:\/\/x.com\/fqeuskadi","https:\/\/www.instagram.com\/fqeuskadi\/","https:\/\/www.youtube.com\/channel\/UCyqLMZSfydAklJH1x-Js97w"]}]}},"_links":{"self":[{"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/pages\/5599","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/comments?post=5599"}],"version-history":[{"count":0,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/pages\/5599\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/media?parent=5599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}